AI assistant
Datalex Plc — Director's Dealing 2020
Jul 20, 2020
1961_dirs_2020-07-20_1ca22d79-8a0d-404d-9f11-187ab85d29ed.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 5123T
Datalex PLC
20 July 2020
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
David Hargaden
2
Reason for the notification
a)
Position/status
Chairman of the Board and Person Discharging Managerial Responsibility
b)
Initial Notification Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Datalex plc
b)
LEI
635400WYGQN85OAHNT58
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of US$0.10 each
ISIN: IE0000527006
b)
Nature of the transaction
Acquisition of Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| €0.299 | 82,083 |
| €0.30 | 82,083 |
d)
Aggregated information
- Aggregated volume
- Price
| Price | Volume |
| €0.2995 | 164,166 |
e)
Date of the transaction
2020-07-16
f)
Place of the transaction
Euronext Dublin, Ireland
g)
Additional Information
This announcement has been issued through the Companies Announcement Service of Euronext Dublin.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
ISEZZGZNMGMGGZM